Original document(15 pages)  中文版
    The present invention relates to one kind of pirarubicin liposome and its preparation process. Pirarubicin possesses relatively high antitumor effect but certain toxic side effect, and the present invention aims at providing one kind of pirarubicin liposome with obvious curative effect, less toxic side effect and good targeting. The pirarubicin liposome consists of medicine component and supplementary material, the medicine component is pirarubicin or pirarubicin hydrochloride, and the supplementary material includes phospholipid and cholesterol. It may be in injection or freeze dried preparation. The pirarubicin liposome is used in treating different kinds of cancer, such as bladder carcinoma, leukemia, mammary cancer, liver cancer, gastric cancer, etc. and has relatively high curative effect.
Application Number
申请号
200510037263 Application Date
申请日
2005.09.15
Title 名称 Pirarubicin liposome and its prepn process
Publication Number
公开号
1931178 Publication Date
公开日
2007.03.21
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K31/7048;A61K9/127;A61P35/00
Applicant(s) Name
申请人
Zhuhai Tsinghua Science & Technology Park Techn R & D Co., Ltd.
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 wenxu
More information 更  多  信  息


 Related patents information
Erigeron breviscapus oral caving fast disintegration tablet and its preparation method
Carboplatin precursor liposome injection and preparing process thereof
Hiliezdum fast-release tablet and preparing method thereof
Biomimetic biological reaction device of cells utilized for screening medication
Method for making glass chip under ordinary laboratory condition
Developing method for Chinese medicine compound secondary new medicine
Integrated process and apparatus for extracting and separating effective Chinese medicine components
Method of separating and concentrating iridoid glycosides and crocin in cape jasmine fruit
Qingkailing prepn for great transfusion and its prepn process
Qingkailing Prepn for great transfusion and its prepn process
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.